Loading publications…
The last 5 uploaded publications
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet, Robert Montal, Daniela Sia, Richard S. Finn (2018). Molecular therapies and precision medicine for hepatocellular carcinoma. Nature Reviews Clinical Oncology, 15(10), pp. 599-616, DOI: 10.1038/s41571-018-0073-4.
Article145 days agoMolecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol, Robert Montal, Laia Bassaganyas, Daniela Sia, Tadatoshi Takayama, Gar-Yang Chau, Vincenzo Mazzaferro, Sasan Roayaie, Han Chu Lee, Norihiro Kokudo, Zhongyang Zhang, Sara Torrecilla, Agrin Moeini, Leonardo Rodríguez‐Carunchio, Edward Gane, Chris Verslype, Adina Croitoru, Umberto Cillo, Manuel de la Mata, L. Lupo, Simone I. Strasser, Joong‐Won Park, Jordi Camps, Manel Solé, Swan N. Thung, Augusto Villanueva, Carol Peña, Gerold Meinhardt, Jordi Bruix, Josep M. Llovet (2018). Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial. Gut, 68(6), pp. 1065-1075, DOI: 10.1136/gutjnl-2018-316408.
Article145 days agoMolecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal, Daniela Sia, Carla Montironi, Wei Qiang Leow, Roger Esteban-Fabró, Roser Pinyol, Miguel Torres‐Martín, Laia Bassaganyas, Agrin Moeini, Judit Peix, Laia Cabellos, Miho Maeda, Carlos Villacorta-Martín, Parissa Tabrizian, Leonardo Rodríguez‐Carunchio, Giancarlo Castellano, Christine Sempoux, Beatriz Mínguez, Timothy M. Pawlik, Ismaïl Labgaa, Lewis R. Roberts, Manel Solé, Maria Isabel Fiel, Swan N. Thung, Josep Fuster, Sasan Roayaie, Augusto Villanueva, M. Schwartz, Josep M. Llovet (2020). Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. Journal of Hepatology, 73(2), pp. 315-327, DOI: 10.1016/j.jhep.2020.03.008.
Article145 days agoObjective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
Riccardo Lencioni, Robert Montal, Ferrán Torres, Joong‐Won Park, Thomas Decaens, Jean‐Luc Raoul, Masatoshi Kudo, Charissa Chang, José Ríos, Valérie Boige, Éric Assenat, Yoon‐Koo Kang, Ho-Yeong Lim, Ian Walters, Josep M. Llovet (2017). Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. Journal of Hepatology, 66(6), pp. 1166-1172, DOI: 10.1016/j.jhep.2017.01.012.
Article145 days agoEvidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
Philipp K. Haber, Marc Puigvehí, Florian Castet, Vennis Lourdusamy, Robert Montal, Parissa Tabrizian, Michael Buckstein, Edward Kim, Augusto Villanueva, Myron Schwartz, Josep M. Llovet (2021). Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020). Gastroenterology, 161(3), pp. 879-898, DOI: 10.1053/j.gastro.2021.06.008.
Article145 days ago